Diversified Healthcare Trust (NASDAQ:DHC) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Diversified Healthcare Trust (NASDAQ:DHC) from a sell rating to a hold rating in a research note issued to investors on Thursday morning.

Separately, B. Riley started coverage on Diversified Healthcare Trust in a report on Thursday, April 3rd. They set a “buy” rating and a $4.50 target price for the company.

Diversified Healthcare Trust Price Performance

Diversified Healthcare Trust stock opened at $2.07 on Thursday. The company has a debt-to-equity ratio of 1.44, a quick ratio of 11.57 and a current ratio of 11.57. The company’s fifty day moving average price is $2.53 and its 200 day moving average price is $2.69. The stock has a market capitalization of $499.36 million, a P/E ratio of -1.29 and a beta of 2.02. Diversified Healthcare Trust has a 1 year low of $2.00 and a 1 year high of $4.24.

Diversified Healthcare Trust (NASDAQ:DHC) last announced its earnings results on Tuesday, February 25th. The real estate investment trust reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.31. Diversified Healthcare Trust had a negative net margin of 26.09% and a negative return on equity of 17.55%. The business had revenue of $379.62 million for the quarter, compared to analyst estimates of $370.97 million.

Diversified Healthcare Trust Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Tuesday, April 22nd will be given a dividend of $0.01 per share. The ex-dividend date of this dividend is Tuesday, April 22nd. This represents a $0.04 dividend on an annualized basis and a yield of 1.93%. Diversified Healthcare Trust’s payout ratio is presently -2.60%.

Institutional Investors Weigh In On Diversified Healthcare Trust

A number of large investors have recently made changes to their positions in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Diversified Healthcare Trust by 41.5% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 384,477 shares of the real estate investment trust’s stock valued at $884,000 after acquiring an additional 112,701 shares during the last quarter. Union Square Park Capital Management LLC boosted its holdings in Diversified Healthcare Trust by 32.1% in the 4th quarter. Union Square Park Capital Management LLC now owns 925,000 shares of the real estate investment trust’s stock valued at $2,128,000 after purchasing an additional 225,000 shares during the last quarter. State of Wyoming grew its stake in shares of Diversified Healthcare Trust by 15.2% in the 4th quarter. State of Wyoming now owns 54,284 shares of the real estate investment trust’s stock valued at $125,000 after buying an additional 7,175 shares during the period. Southport Management L.L.C. increased its holdings in shares of Diversified Healthcare Trust by 20.0% during the 4th quarter. Southport Management L.L.C. now owns 90,000 shares of the real estate investment trust’s stock worth $207,000 after buying an additional 15,000 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. raised its position in shares of Diversified Healthcare Trust by 133.1% during the 4th quarter. Point72 Asia Singapore Pte. Ltd. now owns 44,864 shares of the real estate investment trust’s stock valued at $103,000 after buying an additional 25,614 shares during the period. 75.98% of the stock is currently owned by hedge funds and other institutional investors.

About Diversified Healthcare Trust

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.